Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America, E-Book
- ISBN-10
- 0323584047
- ISBN-13
- 9780323584043
- Category
- Medical
- Pages
- 265
- Language
- English
- Published
- 2018-05-23
- Publisher
- Elsevier Health Sciences
- Authors
- Camilla S. Graham, Stacey B. Trooskin
Description
The field of HCV has changed perhaps faster than any other field in medicine. The Guest Editors have strived to create an issue that is a state-of-the-art analysis of solutions to specific challenges faced in the United States and globally in implementing HCV elimination strategies. They believe that clinicians now have the tools and road maps needed to accomplish this goal. The clinical review articles in this issue accomplish that: Using Existing Health Care Infrastructure To Expand HCV Care; Creating A Reproducible Health Economic Model To Describe The Burden Of HCV And Cost Of Treatment In Any Country; The Best Uses Of Cost-Effectiveness Models In HCV; Increasing Access To HCV Care In Corrections; Cure As Prevention Strategies For HCV In People Who Inject Drugs; Australia Will Eliminate HCV – How It Works; New York Is The First State In The US To Develop An HCV Elimination Strategy; When HCV Diagnostics Are The Barrier To Care; Key Findings From The Checs HCV Cohort Study; Strategies To Reduce HCV Reinfection Rates In People Who Inject Drugs; Strategies To Reduce HCV Reinfection Rates In Men Who Have Sex With Other Men; The Value Of Curing HCV From A Payer’s Perspective; How To Expand Care Capacity In HCV; Strategies To Eliminate HCV In The HIV Coinfected Population; and The US Veteran’s Administration: Lessons Learned And Best Practices For HCV Elimination.
Get the book
Similar books
-
Overcoming Barriers to Eliminate Hepatitis C, an Issue of Infectious Disease Clinics of North America
By Camilla S. Graham, Stacey B. TrooskinThe clinical review articles in this issue accomplish that: Using Existing Health Care Infrastructure To Expand HCV Care; Creating A Reproducible Health Economic Model To Describe The Burden Of HCV And Cost Of Treatment In Any Country; The ...
-
Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report
By Board on Population Health and Public Health Practice, Health and Medicine Division, EngineeringHepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis.
-
Infections in Children, An Issue of Infectious Disease Clinics of North America, E-Book
By Jason G. Newland, Jennifer SchusterRenaud C, Harrison CJ. Human parechovirus 3: the most common viral cause of meningoencephalitis in young ... Pruss H, Finke C, Holtje M, et al. ... Perez-Velez CM, Anderson MS, Robinson CC, et al. Outbreak Encephalitis in US Children ...
-
Disease Control Priorities, Third Edition (Volume 6): HIV/AIDS, STIS, Tuberculosis, and Malaria
By Prabhat JhaThe volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care.
-
A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report
By Board on Population Health and Public Health Practice, Health and Medicine Division, EngineeringHepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis.
-
Opportunities to Improve Opioid Use Disorder and Infectious Disease Services: Integrating Responses to a Dual Epidemic
By Board on Population Health and Public Health Practice, Health and Medicine Division, EngineeringThis is at least in part due to traditional models of substance use disorder care wherein substance use disorder treatment is delivered independently of other medical care, thereby inhibiting the delivery of comprehensive care.
-
Integrating Responses at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics: Proceedings of a Workshop
By Board on Population Health and Public Health Practice, Health and Medicine Division, Engineering... and his postdoctoral training at the Yale University Center for Interdisciplinary Research on AIDS. ... management, evaluation, and capacity building with a focus on promoting the health and well-being of drug users and other ...
-
Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection Updated Version April 2016: Guidelines
By World Health OrganizationThe field of HCV therapeutics continues to evolve rapidly and since the World Health Organization (WHO) issued its first Guidelines for the screening care and treatment of persons with hepatitis C infection in 2014 several new medicines ...
-
Preventing HIV Transmission: The Role of Sterile Needles and Bleach
By Institute of Medicine, National Research Council and Institute of Medicine, Panel on Needle Exchange and Bleach Distribution ProgramsThis volume addresses the interface of two major national problems: the epidemic of HIV-AIDS and the widespread use of illegal injection drugs.
-
Hepatitis C Virus Treatment: Highly Effective Therapy with Direct Acting Antivirals and Associated Viral Resistance
By Kazuaki ChayamaThis book introduces readers to Direct Acting Antiviral (DAAs) agents, newly developed drugs to treat chronic hepatitis C virus infection, which have an excellent anti-viral effect on virus replication.